Domestic backward planting way endangering Chinese medicine quality

On July 19, 2013

China industry research network

        Because our country agriculture dispersive, backward management way and the farmers' own quality is low, in the process of Chinese medicinal materials planting some farmers use of banned pesticides, and have not establish standard, improve the quality of Chinese medicinal materials in Chinese herbal medicine pesticide residues, heavy metal exceeds bid happened frequently. And abroad with the help of a quality advantage began to big push into domestic Chinese medicine market, at present the traditional Chinese medicine (TCM) in the domestic market share has reached a third, direct threat to the healthy development of Chinese medicine industry in China.

        The personage inside course of study thinks, our country should be established as soon as possible, conform to the theory of traditional Chinese medicine of traditional Chinese medicine quality synthetic evaluation system, set up specialized agencies to guide farmers to reasonable use of pesticides, fertilizers. At the same time, enterprises should increase investment in science and technology, improving the quality of TCM products, accelerate the process of the industrialization and internationalization.

        Planting technology backward testing standard is controversial

        Hebei anguo city of Chinese herbal medicine for more than 70000 mu of cultivated area, planting more than 40 varieties and varieties to except YiMi eight qi "medicine". Anguo city as one of Chinese medicine in our country China, nearly 2000 kinds of Chinese medicinal materials, the most of the Chinese medicinal materials, you can purchase in the Chinese medicinal materials of anguo city market.

        Anguo city professional market, there are many traditional Chinese medicinal materials supply of goods from retail, scattered individuals grow to regulation has brought certain difficulties. Due to lack of guidance, medicinal plant and pest control technology generally lag behind, need to rely on chemical fertilizers and pesticides, more HuoZhuang village of anguo city, head of the Chinese herbal medicine cultivation of science and technology professional cooperatives HuoZhiJun said, "medicinal herbs quality problem may be more, do not rule out using pesticide is disabled state."

        Safety testing is at an important link in traditional Chinese medicinal materials quality, but in the detection of pesticide residues and heavy metals, enterprises are faced with standard not unified. Some think, head of the Chinese traditional medicine enterprises, what kind of medicinal materials is qualified, there is no a unified theory. So-called qualified, not only refers to no pesticide residue and heavy metal residues exceeding the standards, but also have effect.

        At the end of 2012, Hong Kong department of health announced the fifth stage of "standard of traditional Chinese medicine of Hong Kong", covers 42 kinds of commonly used traditional Chinese medicine safety and quality reference standards, for medicine, pesticide residues and heavy metals content composition determination method of index made detailed provisions. Experts believe that the standard is reasonable, have an operational, is questionable. "Of our country's execution of Chinese herbal medicine on the market is the national pharmacopoeia 2012 edition, compared with the actual situation, some of the pharmacology of traditional Chinese medicine medicinal properties to let a person more difficult to grasp, Chinese herbal medicine is the quintessence, cultured is pure pharmacological potency."

        Appraisal committee member, deputy director of Chinese medicinal materials in hebei province Han Shikai said: "now of Chinese medicinal materials inspection standard adopt western standards of analytical chemistry. Chinese medicine is the clinical curative effect of conclusion, the party is the foundation of modern Chinese medicine, pay attention to the compatibility and dosage forms corresponding to each other, but now the study is open party, herbs as medicines, traditional Chinese medicine (TCM) to western medicine testing standard."

        Low bid prices via foreign Chinese medicine herbs

        With the change of the disease and the medical model, the "return to nature" and the rise of "green" consumption, natural medicines and traditional plant medicine's status has improved increasingly. Based on this, the foreign medical scholars and manufacturers are committed to seeking clues to new drugs from the plant medicine, trying to opening up the new way of drug development, especially in Germany, Japan, Korea and other countries. A data shows, in the global Chinese medicine market, Japan accounted for 80% share of South Korea's by 10%, while China accounted for only 5%.

        International medicine market occupied not only, and the traditional Chinese medicine also big push into the Chinese market, the sunway pharmaceutical group chairman and President Li Zhenjiang said, "according to incomplete statistics, imports of Chinese traditional medicine has been in the domestic market accounted for a third." In fact, the vast majority of the Chinese traditional medicine, traditional Chinese medicinal materials is from China's cheap to buy abroad after deep processing, medicine sell back home again, and the price. In ginkgo biloba, Germany every year a large number of cheap imports from China, to produce a product with the price of the original value of more than 10 times higher than that of products back to China. Experts said that the Chinese traditional medicine science and technology content high, with makings fastidious, location advantages of the simple and clear is the reason of its rapid development.

        Li Zhenjiang said: "the Chinese medicine's biggest depend on and quality advantages, namely the high degree of quality standards, especially the plant medicine preparations of some countries in Europe, with standard extract active ingredients or commonly labeled dose, it also reflects the quality standards in China compared with the owe normalization, standardization and reproducibility is poor."

        Experts believe that the traditional Chinese medicine of proprietary Chinese medicine in our country market share has reached a third, behind the resource crisis is bound to intensify Chinese medicine and Chinese medicine research and utilization of resources of international competition. Li Zhenjiang said that Japan, South Korea, southeast Asia and western European companies from our low purchase API on the rough machining, after back to domestic refining extract preparation via phenomenon intensified at a high price, this is not only the impact on the traditional Chinese medicine industry in China is a big, a threat to the healthy development of our country's economy will be.

        Perfect laws and regulations to establish comprehensive evaluation system

        China commodity society, vice chairman, Beijing university of Chinese medicine Chinese medicine professional doctoral tutor professor Zhang Guijun thinks, should have correspondence quality evaluation indexes and clinical curative effect, in traditional Chinese medicine efficacy components based on the established quality standards. This is applicable to real clinical treatment standards at the core of Chinese medicine, also is to establish a theory of traditional Chinese medicine of traditional Chinese medicine the foundation of quality comprehensive evaluation system

        "Instructions on the use of highly toxic pesticides are generally defined scope of the agricultural sector is to guide farmers to use correctly, with some farmers use case, no relevant laws and regulations restrict, government level regulation is lacking." Some Chinese medicine, said an official with the company to solve this problem need to related departments to formulate relevant laws and regulations, and intensify law enforcement.

        At the same time, Chinese traditional medicine enterprises should also increase investment in science and technology research and development, improve the technological content of products, constantly improving the quality of TCM products. Now have hundreds of Chinese medicine research institutions in our country, more than 2000 proprietary Chinese medicine production enterprises, can produce more than 4000 kinds of traditional Chinese, but less important innovation breakthrough, less into realistic productivity. 40 years after the advent of artemisinin, there is no second can match results.

        Li Zhenjiang thinks, must increase investment in traditional Chinese medicine scientific research, especially to increase the material base of Chinese traditional medicine research, adopt the new mode of production and mode of operation and management, develop new products, improve product quality.

The original link: http://www.chinairn.com/news/20130719/110757684.html

(this site editor Wang Zhong one)